Guidance for industry : biological product deviation reporting for licensed manufacturers of biological products other than blood and blood components.

Bibliographic Details
Corporate Authors:	Center for Biologics Evaluation and Research (U.S.), Center for Drug Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research, [2006]
Subjects:	Biological products > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS112510

Description
Item Description:	Title from PDF title page (viewed on May 12, 2009). "October 2006". Electronic resource.
Physical Description:	i, 18 pages : digital, PDF file.
Format:	Mode of access: Internet at the FDA CBER web site. Address as of 5/12/09: http://www.fda.gov/cber/gdlns/devnbld.pdf ; current access is available via PURL.
Bibliography:	Includes bibliographical references (page 18).